JP2021514999A5 - - Google Patents
Info
- Publication number
- JP2021514999A5 JP2021514999A5 JP2020545293A JP2020545293A JP2021514999A5 JP 2021514999 A5 JP2021514999 A5 JP 2021514999A5 JP 2020545293 A JP2020545293 A JP 2020545293A JP 2020545293 A JP2020545293 A JP 2020545293A JP 2021514999 A5 JP2021514999 A5 JP 2021514999A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- alkoxy
- halo
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637147P | 2018-03-01 | 2018-03-01 | |
| US62/637,147 | 2018-03-01 | ||
| PCT/US2019/020395 WO2019169326A1 (en) | 2018-03-01 | 2019-03-01 | Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514999A JP2021514999A (ja) | 2021-06-17 |
| JP2021514999A5 true JP2021514999A5 (cg-RX-API-DMAC7.html) | 2022-02-17 |
| JP7305664B2 JP7305664B2 (ja) | 2023-07-10 |
Family
ID=67767960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545293A Active JP7305664B2 (ja) | 2018-03-01 | 2019-03-01 | タンパク質アルギニンメチルトランスフェラーゼの阻害剤としてのエタンジアミン-複素環誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11028083B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3758698A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7305664B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111867584A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019226585A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020017541A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3092579A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019169326A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020017541A2 (pt) | 2018-03-01 | 2020-12-22 | Board Of Regents, The University Of Texas System | Composto de fórmula estrutural i ou sal do mesmo, composição farmacêutica, método para inibição de prmt, método para modular expressão de gene, e método para tratamento de uma doença mediada por prmt |
| WO2022192527A1 (en) * | 2021-03-12 | 2022-09-15 | Board Of Regents, The University Of Texas System | Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5002941A (en) | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors |
| JP2004149429A (ja) * | 2002-10-29 | 2004-05-27 | Takeda Chem Ind Ltd | インドール化合物およびその用途 |
| EP2221053A1 (de) * | 2009-02-20 | 2010-08-25 | Albert-Ludwigs-Universität Freiburg | Pharmazeutische Zusammensetzung enthaltend Hemmstoffe der Proteinmethyltransferase I und deren Verwendung zur Behandlung von Tumorerkrankungen |
| US9593109B2 (en) * | 2011-08-26 | 2017-03-14 | Cymabay Therapeutics, Inc. | Bicyclic agonists of GPR131 and uses thereof |
| WO2014153172A1 (en) | 2013-03-14 | 2014-09-25 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| US9133189B2 (en) * | 2013-03-14 | 2015-09-15 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| CA2903394C (en) * | 2013-03-14 | 2021-08-31 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| JP2016514164A (ja) | 2013-03-14 | 2016-05-19 | エピザイム,インコーポレイティド | アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用 |
| EP3363434A1 (en) * | 2013-03-14 | 2018-08-22 | Epizyme Inc | Arginine methyltransferase inhibitors and uses thereof |
| EP2970181B1 (en) * | 2013-03-14 | 2017-06-07 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| EP2970135B1 (en) * | 2013-03-14 | 2018-07-18 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| US9120757B2 (en) * | 2013-03-14 | 2015-09-01 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US9394258B2 (en) * | 2013-03-14 | 2016-07-19 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| US20160039767A1 (en) | 2013-03-14 | 2016-02-11 | Epizyme, Inc. | Pyrazole derivatives as prmt1 inhibitors and uses thereof |
| AU2015301196A1 (en) | 2014-08-04 | 2017-01-12 | Epizyme, Inc. | PRMT5 inhibitors and uses thereof |
| US20170283400A1 (en) | 2014-09-17 | 2017-10-05 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2016044576A1 (en) | 2014-09-17 | 2016-03-24 | Epizyme, Inc. | Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor |
| US20170280720A1 (en) * | 2014-09-17 | 2017-10-05 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2016044626A1 (en) | 2014-09-17 | 2016-03-24 | Epizyme, Inc. | Arginine methyltransferase inhibitors and uses thereof |
| WO2017136699A1 (en) | 2016-02-05 | 2017-08-10 | Epizyme, Inc | Arginine methyltransferase inhibitors and uses thereof |
| KR102148587B1 (ko) | 2016-02-23 | 2020-08-26 | 화이자 인코포레이티드 | 6,7-디히드로-5H-피라졸로[5,1-b][1,3]옥사진-2-카르복스아미드 화합물 |
| BR112020017541A2 (pt) | 2018-03-01 | 2020-12-22 | Board Of Regents, The University Of Texas System | Composto de fórmula estrutural i ou sal do mesmo, composição farmacêutica, método para inibição de prmt, método para modular expressão de gene, e método para tratamento de uma doença mediada por prmt |
-
2019
- 2019-03-01 BR BR112020017541-2A patent/BR112020017541A2/pt not_active Application Discontinuation
- 2019-03-01 JP JP2020545293A patent/JP7305664B2/ja active Active
- 2019-03-01 WO PCT/US2019/020395 patent/WO2019169326A1/en not_active Ceased
- 2019-03-01 CA CA3092579A patent/CA3092579A1/en active Pending
- 2019-03-01 CN CN201980020505.5A patent/CN111867584A/zh active Pending
- 2019-03-01 US US16/290,675 patent/US11028083B2/en not_active Expired - Fee Related
- 2019-03-01 AU AU2019226585A patent/AU2019226585A1/en not_active Abandoned
- 2019-03-01 EP EP19761558.6A patent/EP3758698A4/en not_active Withdrawn
-
2021
- 2021-05-04 US US17/307,568 patent/US11725008B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519308A5 (cg-RX-API-DMAC7.html) | ||
| US12077554B2 (en) | CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer | |
| US9717730B2 (en) | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use | |
| JP2015534579A5 (cg-RX-API-DMAC7.html) | ||
| JP2019510832A5 (cg-RX-API-DMAC7.html) | ||
| JP2013507415A5 (cg-RX-API-DMAC7.html) | ||
| JP2024511996A5 (cg-RX-API-DMAC7.html) | ||
| JP2020511467A5 (cg-RX-API-DMAC7.html) | ||
| PH12018550049A1 (en) | Protein kinase inhibitor, preparation method and medical use thereof | |
| RU2014151565A (ru) | Способ получения n-[5-(3,5-дифторбензил)-1н-индазол-3-ил]-4-(4-метилпиперазин-1-ил)-2-(тетрагидропиран-4-иламино)бензамида | |
| JP2016506916A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523784A5 (cg-RX-API-DMAC7.html) | ||
| JP2022540421A5 (cg-RX-API-DMAC7.html) | ||
| JP2022527398A (ja) | 2-(2,6-ジオキソピペリジン-3-イル)-4-((2-フルオロ-4-((3-モルホリノアゼチジン-1-イル)メチル)ベンジル)アミノ)イソインドリン-1,3-ジオンを使用する非ホジキンリンパ腫の処置方法 | |
| MXPA05007857A (es) | Moduladores derivados de indol de receptores nucleares de hormonas esteroideas. | |
| JP2019516684A5 (cg-RX-API-DMAC7.html) | ||
| JP2008540554A5 (cg-RX-API-DMAC7.html) | ||
| JP2019524714A5 (cg-RX-API-DMAC7.html) | ||
| RU2014108885A (ru) | Ингибирование транзиторного рецепторного потенциала ионного канала trpa1 | |
| JP2014532730A5 (ja) | オピオイド受容体の調節物質およびそれを含む薬学的組成物 | |
| EP3423112A1 (en) | Hsp90 inhibitor drug conjugates | |
| JP2009531441A5 (cg-RX-API-DMAC7.html) | ||
| JP2015522551A5 (cg-RX-API-DMAC7.html) | ||
| JP2017525740A5 (cg-RX-API-DMAC7.html) | ||
| CN111818925A (zh) | Cdk4/6抑制剂与egfr抑制剂联合在制备治疗肿瘤疾病的药物中的用途 |